1. Home
  2. RNA vs TNL Comparison

RNA vs TNL Comparison

Compare RNA & TNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • TNL
  • Stock Information
  • Founded
  • RNA 2012
  • TNL 1990
  • Country
  • RNA United States
  • TNL United States
  • Employees
  • RNA N/A
  • TNL N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • TNL Hotels/Resorts
  • Sector
  • RNA Health Care
  • TNL Consumer Discretionary
  • Exchange
  • RNA Nasdaq
  • TNL Nasdaq
  • Market Cap
  • RNA 3.7B
  • TNL 3.6B
  • IPO Year
  • RNA 2020
  • TNL N/A
  • Fundamental
  • Price
  • RNA $31.12
  • TNL $55.16
  • Analyst Decision
  • RNA Strong Buy
  • TNL Buy
  • Analyst Count
  • RNA 10
  • TNL 10
  • Target Price
  • RNA $65.80
  • TNL $62.00
  • AVG Volume (30 Days)
  • RNA 1.3M
  • TNL 545.3K
  • Earning Date
  • RNA 03-07-2025
  • TNL 02-19-2025
  • Dividend Yield
  • RNA N/A
  • TNL 3.50%
  • EPS Growth
  • RNA N/A
  • TNL 10.24
  • EPS
  • RNA N/A
  • TNL 5.82
  • Revenue
  • RNA $10,117,000.00
  • TNL $3,864,000,000.00
  • Revenue This Year
  • RNA N/A
  • TNL $3.73
  • Revenue Next Year
  • RNA N/A
  • TNL $4.60
  • P/E Ratio
  • RNA N/A
  • TNL $9.52
  • Revenue Growth
  • RNA N/A
  • TNL 3.04
  • 52 Week Low
  • RNA $13.73
  • TNL $39.91
  • 52 Week High
  • RNA $56.00
  • TNL $58.95
  • Technical
  • Relative Strength Index (RSI)
  • RNA 44.06
  • TNL 50.87
  • Support Level
  • RNA $31.14
  • TNL $55.26
  • Resistance Level
  • RNA $33.37
  • TNL $58.95
  • Average True Range (ATR)
  • RNA 1.67
  • TNL 1.62
  • MACD
  • RNA -0.16
  • TNL -0.04
  • Stochastic Oscillator
  • RNA 11.27
  • TNL 38.57

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

Share on Social Networks: